Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

PHASE3CompletedINTERVENTIONAL
Enrollment

809

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

olodaterol

fixed dose combination

DRUG

tiotropium

fixed dose combination

DRUG

placebo

Trial Locations (78)

Unknown

1237.26.10620 Boehringer Ingelheim Investigational Site, Jasper

1237.26.10618 Boehringer Ingelheim Investigational Site, Stamford

1237.26.10619 Boehringer Ingelheim Investigational Site, Clearwater

1237.26.10614 Boehringer Ingelheim Investigational Site, Tampa

1237.26.10616 Boehringer Ingelheim Investigational Site, Duluth

1237.26.10613 Boehringer Ingelheim Investigational Site, St Louis

1237.26.10615 Boehringer Ingelheim Investigational Site, Greensboro

1237.26.10603 Boehringer Ingelheim Investigational Site, Columbus

1237.26.10621 Boehringer Ingelheim Investigational Site, Dayton

1237.26.10612 Boehringer Ingelheim Investigational Site, Toledo

1237.26.10605 Boehringer Ingelheim Investigational Site, Oklahoma City

1237.26.10606 Boehringer Ingelheim Investigational Site, Medford

1237.26.10610 Boehringer Ingelheim Investigational Site, East Providence

1237.26.10607 Boehringer Ingelheim Investigational Site, Gaffney

1237.26.10617 Boehringer Ingelheim Investigational Site, Greenville

1237.26.10608 Boehringer Ingelheim Investigational Site, Spartanburg

1237.26.10604 Boehringer Ingelheim Investigational Site, Union

1237.26.10609 Boehringer Ingelheim Investigational Site, Boerne

1237.26.10602 Boehringer Ingelheim Investigational Site, San Antonio

1237.26.10601 Boehringer Ingelheim Investigational Site, Morgantown

1237.26.61004 Boehringer Ingelheim Investigational Site, Concord

1237.26.61002 Boehringer Ingelheim Investigational Site, Daw Park

1237.26.61003 Boehringer Ingelheim Investigational Site, Toorak Gardens

1237.26.61007 Boehringer Ingelheim Investigational Site, Woodville

1237.26.61005 Boehringer Ingelheim Investigational Site, Murdoch

1237.26.61001 Boehringer Ingelheim Investigational Site, Nedlands

1237.26.43004 Boehringer Ingelheim Investigational Site, Feldbach

1237.26.43002 Boehringer Ingelheim Investigational Site, Grieskirchen

1237.26.43003 Boehringer Ingelheim Investigational Site, Linz

1237.26.43006 Boehringer Ingelheim Investigational Site, Linz

1237.26.43001 Boehringer Ingelheim Investigational Site, Thalheim bei Wels

1237.26.11605 Boehringer Ingelheim Investigational Site, Moncton

1237.26.11609 Boehringer Ingelheim Investigational Site, Courtice

1237.26.11608 Boehringer Ingelheim Investigational Site, Sarnia

1237.26.11606 Boehringer Ingelheim Investigational Site, Toronto

1237.26.11607 Boehringer Ingelheim Investigational Site, Toronto

1237.26.11601 Boehringer Ingelheim Investigational Site, Windsor

1237.26.11611 Boehringer Ingelheim Investigational Site, Mirabel

1237.26.11602 Boehringer Ingelheim Investigational Site, Point Claire

1237.26.11603 Boehringer Ingelheim Investigational Site, Sherbrooke

1237.26.49610 Boehringer Ingelheim Investigational Site, Bamberg

1237.26.49611 Boehringer Ingelheim Investigational Site, Berlin

1237.26.49616 Boehringer Ingelheim Investigational Site, Berlin

1237.26.49609 Boehringer Ingelheim Investigational Site, Bochum

1237.26.49607 Boehringer Ingelheim Investigational Site, Dresden

1237.26.49612 Boehringer Ingelheim Investigational Site, Frankfurt

1237.26.49615 Boehringer Ingelheim Investigational Site, Halberstadt

1237.26.49606 Boehringer Ingelheim Investigational Site, Hamburg

1237.26.49608 Boehringer Ingelheim Investigational Site, Hanover

1237.26.49603 Boehringer Ingelheim Investigational Site, Hettstedt

1237.26.49604 Boehringer Ingelheim Investigational Site, Leipzig

1237.26.49605 Boehringer Ingelheim Investigational Site, Leipzig

1237.26.49601 Boehringer Ingelheim Investigational Site, Lübeck

1237.26.49602 Boehringer Ingelheim Investigational Site, Rüdersdorf

1237.26.49614 Boehringer Ingelheim Investigational Site, Schwerin

1237.26.49613 Boehringer Ingelheim Investigational Site, Wiesloch

1237.26.30005 Boehringer Ingelheim Investigational Site, Athens

1237.26.30002 Boehringer Ingelheim Investigational Site, Heraklion

1237.26.30001 Boehringer Ingelheim Investigational Site, Nafplion

1237.26.30004 Boehringer Ingelheim Investigational Site, Serres

1237.26.30003 Boehringer Ingelheim Investigational Site, Thessaloniki

1237.26.64001 Boehringer Ingelheim Investigational Site, Greenlane East Auckland NZ

1237.26.47003 Boehringer Ingelheim Investigational Site, Hamar

1237.26.47001 Boehringer Ingelheim Investigational Site, Hønefoss

1237.26.47002 Boehringer Ingelheim Investigational Site, Kløfta

1237.26.47004 Boehringer Ingelheim Investigational Site, Lierskogen

1237.26.42103 Boehringer Ingelheim Investigational Site, Bardejov

1237.26.42104 Boehringer Ingelheim Investigational Site, Humenné

1237.26.42102 Boehringer Ingelheim Investigational Site, Spišská Nová Ves

1237.26.42101 Boehringer Ingelheim Investigational Site, Vyšné Hágy

1237.26.27601 Boehringer Ingelheim Investigational Site, Cape Town

1237.26.27602 Boehringer Ingelheim Investigational Site, Cape Town

1237.26.27604 Boehringer Ingelheim Investigational Site, Cape Town

1237.26.27605 Boehringer Ingelheim Investigational Site, Durban

1237.26.46004 Boehringer Ingelheim Investigational Site, Höllviken

1237.26.46001 Boehringer Ingelheim Investigational Site, Lund

1237.26.46002 Boehringer Ingelheim Investigational Site, Stockholm

1237.26.46003 Boehringer Ingelheim Investigational Site, Uddevalla

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY